Mycoplasma fermentans infection induces human necrotic neuronal cell death via IFITM3-mediated amyloid-β (1-42)

Kyu-Young Sim1,2, Yeongseon Byeon2, So-Eun Bae1

  • 1Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.

Scientific Reports
|April 26, 2023
PubMed

Insights

Mycoplasma fermentans infects human brain cells, causing cell death via amyloid-beta deposition. Interferon-induced transmembrane protein 3 (IFITM3) plays a key role in this neuroinflammatory process.

Area of Science:

  • Neuroscience
  • Microbiology
  • Infectious Diseases

Background:

  • Mycoplasma fermentans is linked to neurological diseases and found in brain lesions.
  • Its pathogenic role in human neuronal cells remains uninvestigated.

Purpose of the Study:

  • To investigate the pathogenic mechanisms of Mycoplasma fermentans in human neuronal cells.
  • To elucidate the role of M. fermentans in neuronal cell death and neurological disease progression.

Main Methods:

  • Infection of human neuronal cells and brain organoids with M. fermentans.
  • Amyloid-beta deposition analysis and amyloid precursor protein depletion using shRNA.
  • RNA sequencing (RNA-seq) for differential gene expression analysis.
  • Interferon-induced transmembrane protein 3 (IFITM3) knockdown and toll-like receptor 4 (TLR4) antagonist treatment.

Main Results:

  • M. fermentans infects and replicates in human neuronal cells, inducing necrotic cell death.
  • Necrotic cell death is associated with intracellular amyloid-beta (1-42) deposition.
  • IFITM3 is upregulated upon M. fermentans infection and mediates amyloid-beta deposition and cell death.
  • TLR4 signaling pathway is involved in IFITM3 upregulation.
  • M. fermentans infection causes necrotic neuronal cell death in brain organoids.

Conclusions:

  • Neuronal cell infection by M. fermentans directly induces necrotic cell death.
  • This process is mediated by IFITM3-dependent amyloid-beta deposition.
  • M. fermentans may contribute to neurological disease development and progression.